CELLIBRE INC
DNA-based biomanufacturing platform using synthetic biology to produce materials and chemicals
- Sector
- Biotech
- Headquarters
- SAN DIEGO, CA
- Founded
- 2017
- Latest Form D
- $6.7M, Oct 2024
- Total capital
- $22.8M
- Federal grants
- $2M
- 2 awards · 2024–2025
- Rank in peer group#4 of 37
- Private capital raised
- $20.8M
- 3 Form D · last Oct 2024
- 25 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 18 pending
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · A microbial engineering platform for sustainable, scalable, and cost-effective production of pharmaceutical grade cannabinoids and related compounds$1.0M
- Private capital raisedForm D · SEC · 3rd filing$6.7M
- Federal grantHealth and Human S · Phase II · A microbial engineering platform for sustainable, scalable, and cost-effective production of pharmaceutical grade cannabinoids and related compounds$1.0M
- Private capital raisedForm D · SEC · 2nd filing$9.9M
- Private capital raisedForm D · SEC · 1st filing$4.2M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 37 peers
Line = medianBiotech · Platform
- Federal grants#4 · top 11%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Spiros KambourakisResearcherExecutive Officer, DirectorLinked by $2M in grants as PI
- Benjamin ChiarelliExecutive Officer, DirectorNamed in SEC Form D filings
- Nicky CaiazzaExecutive Officer, DirectorNamed in SEC Form D filings
- Scott ZingheimExecutive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 18- PendingPrenyltransferases And Methods Of Making And Use ThereofUSPTOApplication 17909733
- PendingCellular Engineering To Improve Cannabinoid Production In Microbial CellsUSPTOApplication 18701608
- PendingOptimized Biosynthesis Pathway For Cannabinoid BiosynthesisUSPTOApplication 18701596
Show all 18 patent records
- Prenyltransferases And Methods Of Making And Use ThereofNov 13, 2025 · Application 17909733Pending
- Cellular Engineering To Improve Cannabinoid Production In Microbial CellsApr 24, 2025 · Application 18701608Pending
- Optimized Biosynthesis Pathway For Cannabinoid BiosynthesisDec 5, 2024 · Application 18701596Pending
- Engineered Enzymes, Cells, And Methods For Producing Cannabinoid Precursors And CannabinoidsOct 31, 2024 · Application 18290561Pending
- Engineered Cells, Enzymes, And Methods For Producing CannabinoidsJul 11, 2024 · Application 18560883Pending
- Production Of Cannabinoids And Engineered Cells ThereforApplication PCTUS2023085853Pending
- Enzymes And Methods For The Synthesis Of CannabinoidsApplication PCTUS2023084953Pending
- Optimized Biosynthesis Pathway For Cannabinoid BiosynthesisApplication PCTUS2022046924Pending
- Cellular Engineering To Improve Cannabinoid Production In Microbial CellsApplication PCTUS2022046926Pending
- Engineered Enzymes, Cells, And Methods For Producing Cannabinoid Precursors And CannabinoidsApplication PCTUS2022029327Pending
- Engineered Cells, Enzymes, And Methods For Producing CannabinoidsApplication PCTUS2022029326Pending
- Prenyltransferases And Methods Of Making And Use ThereofApplication PCTUS2021021413Pending
- Production Of Cannabinoids And Engineered Cells ThereforApplication 19142525Pending
- Enzymes And Methods For The Synthesis Of Bakuchiol And DerivativesApplication 19497985Pending
- Improved Enzymes And Methods For The Synthesis Of CannabinoidsApplication 19141576Pending
- Engineered Cells And Methods For The Synthesis Of Caffeoyltyramine And FeruloyltyramineApplication PCTUS2025013036Pending
- Enzymes And Methods For The Synthesis Of Bakuchiol And DerivativesApplication PCTUS2024036457Pending
- Engineered Cells And Methods For The Synthesis Of Caffeoyltyramine And FeruloyltyramineApplication 63625909Pending
Related companies, and why
- SAVARA, INC.Similar federal contract value in Biotech · null in contracts
- MARKER THERAPEUTICS, INC.Similar federal contract value in Biotech · null in contracts
- ACHIEVE LIFE SCIENCES, INC.Similar federal contract value in Biotech · null in contracts
- ALIDA BIOSCIENCES, INC.Similar federal contract value in Biotech · null in contracts
- RODIN THERAPEUTICS, INC.Similar federal contract value in Biotech · null in contracts
- OSSIUM HEALTH INCSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .